| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | microvillus assembly | 3.27e-05 | 28 | 46 | 3 | GO:0030033 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.85e-05 | 5 | 46 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | microvillus organization | 5.92e-05 | 34 | 46 | 3 | GO:0032528 | |
| Domain | CNH | 3.78e-06 | 14 | 42 | 3 | SM00036 | |
| Domain | CNH | 4.72e-06 | 15 | 42 | 3 | PF00780 | |
| Domain | CNH | 4.72e-06 | 15 | 42 | 3 | PS50219 | |
| Domain | CNH_dom | 4.72e-06 | 15 | 42 | 3 | IPR001180 | |
| Domain | VPS13 | 1.48e-05 | 3 | 42 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.48e-05 | 3 | 42 | 2 | PF16910 | |
| Domain | VPS13 | 1.48e-05 | 3 | 42 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.48e-05 | 3 | 42 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.48e-05 | 3 | 42 | 2 | IPR031642 | |
| Domain | VPS13_C | 2.95e-05 | 4 | 42 | 2 | PF16909 | |
| Domain | SHR-BD | 2.95e-05 | 4 | 42 | 2 | IPR009543 | |
| Domain | VPS13_C | 2.95e-05 | 4 | 42 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.95e-05 | 4 | 42 | 2 | PF06650 | |
| Domain | ATG_C | 4.92e-05 | 5 | 42 | 2 | PF09333 | |
| Domain | Autophagy-rel_C | 4.92e-05 | 5 | 42 | 2 | IPR015412 | |
| Domain | VPS13_N | 1.37e-04 | 8 | 42 | 2 | IPR026854 | |
| Domain | Chorein_N | 1.37e-04 | 8 | 42 | 2 | PF12624 | |
| Domain | Kinase-like_dom | 1.25e-03 | 542 | 42 | 6 | IPR011009 | |
| Domain | LRRCT | 2.35e-03 | 32 | 42 | 2 | PF01463 | |
| Domain | ARM-type_fold | 6.93e-03 | 339 | 42 | 4 | IPR016024 | |
| Domain | - | 7.29e-03 | 57 | 42 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 7.54e-03 | 58 | 42 | 2 | IPR013088 | |
| Domain | Ser/Thr_kinase_AS | 8.29e-03 | 357 | 42 | 4 | IPR008271 | |
| Domain | S_TKc | 8.45e-03 | 359 | 42 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 8.70e-03 | 362 | 42 | 4 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 1.02e-02 | 379 | 42 | 4 | IPR017441 | |
| Domain | Pkinase | 1.04e-02 | 381 | 42 | 4 | PF00069 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 1.91e-05 | 22 | 34 | 3 | M39821 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 9.42e-05 | 37 | 34 | 3 | MM14899 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.84e-04 | 119 | 34 | 4 | MM14901 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CUL5 LAMA3 FOLH1B PTPN13 DAAM1 TECTA LRRN1 VPS13C DNAH14 MINK1 ASH1L PRKACB | 3.65e-07 | 1489 | 46 | 12 | 28611215 |
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 9.74e-07 | 15 | 46 | 3 | 22797597 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12406094 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19036967 | ||
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 1.71e-06 | 2 | 46 | 2 | 17196930 | |
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 5.13e-06 | 3 | 46 | 2 | 30093493 | |
| Pubmed | TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes. | 5.13e-06 | 3 | 46 | 2 | 33087848 | |
| Pubmed | MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold protein TANC1. | 5.13e-06 | 3 | 46 | 2 | 18930710 | |
| Pubmed | Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. | 5.13e-06 | 3 | 46 | 2 | 34504076 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 15498460 | ||
| Pubmed | The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane. | 1.71e-05 | 5 | 46 | 2 | 26571211 | |
| Pubmed | 1.89e-05 | 421 | 46 | 6 | 36976175 | ||
| Pubmed | TNIK PTPN13 DAAM1 MAP4K4 PI4KA MINK1 ATP6V0A2 VPS13A EFR3A PRKACB | 1.97e-05 | 1487 | 46 | 10 | 33957083 | |
| Pubmed | SEL1L PTPN13 DAAM1 CNOT10 PI4KA MINK1 ATP6V0A2 ARMC8 IWS1 EFR3A | 2.09e-05 | 1497 | 46 | 10 | 31527615 | |
| Pubmed | 2.46e-05 | 127 | 46 | 4 | 30442766 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 31619968 | ||
| Pubmed | Gata2 specifies serotonergic neurons downstream of sonic hedgehog. | 2.56e-05 | 6 | 46 | 2 | 14973276 | |
| Pubmed | PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity. | 3.58e-05 | 7 | 46 | 2 | 23229899 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 5.79e-05 | 313 | 46 | 5 | 38270169 | |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 6.51e-05 | 163 | 46 | 4 | 23333304 | |
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 35027733 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.39e-04 | 377 | 46 | 5 | 38117590 | |
| Pubmed | ZW10 links mitotic checkpoint signaling to the structural kinetochore. | 1.54e-04 | 14 | 46 | 2 | 15824131 | |
| Pubmed | Ascl1/Mash1 is required for the development of central serotonergic neurons. | 1.54e-04 | 14 | 46 | 2 | 15133515 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 29689292 | ||
| Pubmed | MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation. | 1.92e-04 | 216 | 46 | 4 | 32640226 | |
| Pubmed | An interspecific linkage map of mouse chromosome 15 positioned with respect to the centromere. | 2.30e-04 | 17 | 46 | 2 | 1354638 | |
| Pubmed | 2.88e-04 | 19 | 46 | 2 | 33046550 | ||
| Pubmed | Pet-1 is required across different stages of life to regulate serotonergic function. | 3.20e-04 | 20 | 46 | 2 | 20818386 | |
| Pubmed | Neurogenin3 restricts serotonergic neuron differentiation to the hindbrain. | 3.20e-04 | 20 | 46 | 2 | 25392491 | |
| Pubmed | 3.54e-04 | 21 | 46 | 2 | 19542360 | ||
| Pubmed | Transcriptional repression coordinates the temporal switch from motor to serotonergic neurogenesis. | 3.54e-04 | 21 | 46 | 2 | 17922007 | |
| Pubmed | 3.54e-04 | 21 | 46 | 2 | 32492250 | ||
| Pubmed | Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. | 3.89e-04 | 22 | 46 | 2 | 9324354 | |
| Pubmed | 4.27e-04 | 1049 | 46 | 7 | 27880917 | ||
| Pubmed | Continued expression of GATA3 is necessary for cochlear neurosensory development. | 4.64e-04 | 24 | 46 | 2 | 23614009 | |
| Pubmed | Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons. | 5.04e-04 | 25 | 46 | 2 | 19088086 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.21e-04 | 281 | 46 | 4 | 28706196 | |
| Pubmed | 5.34e-04 | 777 | 46 | 6 | 35844135 | ||
| Pubmed | 5.42e-04 | 284 | 46 | 4 | 29459677 | ||
| Pubmed | 5.45e-04 | 26 | 46 | 2 | 23536097 | ||
| Pubmed | 5.88e-04 | 27 | 46 | 2 | 27789623 | ||
| Pubmed | 5.88e-04 | 27 | 46 | 2 | 19208226 | ||
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 6.33e-04 | 28 | 46 | 2 | 24462114 | |
| Pubmed | 6.55e-04 | 529 | 46 | 5 | 14621295 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 6.95e-04 | 536 | 46 | 5 | 15840001 | |
| Pubmed | 6.95e-04 | 1139 | 46 | 7 | 36417873 | ||
| Pubmed | 7.06e-04 | 538 | 46 | 5 | 10512203 | ||
| Pubmed | 8.66e-04 | 322 | 46 | 4 | 26514267 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 8.73e-04 | 564 | 46 | 5 | 21565611 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 9.08e-04 | 569 | 46 | 5 | 30639242 | |
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 9.90e-04 | 35 | 46 | 2 | 37381005 | |
| Pubmed | 1.07e-03 | 591 | 46 | 5 | 15231748 | ||
| Pubmed | 1.10e-03 | 153 | 46 | 3 | 10718198 | ||
| Interaction | RHOQ interactions | 6.31e-06 | 442 | 46 | 8 | int:RHOQ | |
| Interaction | RHOB interactions | TNIK ARHGDIA PTPN13 DAAM1 MAP4K4 PI4KA MINK1 ASH1L VPS13A EFR3A | 1.56e-05 | 840 | 46 | 10 | int:RHOB |
| Interaction | EPB41L4A interactions | 1.64e-05 | 140 | 46 | 5 | int:EPB41L4A | |
| Interaction | NTRK3 interactions | 2.06e-05 | 374 | 46 | 7 | int:NTRK3 | |
| Interaction | DNAJC5 interactions | 2.20e-05 | 378 | 46 | 7 | int:DNAJC5 | |
| Interaction | NANOS2 interactions | 2.79e-05 | 26 | 46 | 3 | int:NANOS2 | |
| Interaction | FANCD2OS interactions | 2.79e-05 | 26 | 46 | 3 | int:FANCD2OS | |
| Interaction | LYN interactions | 3.04e-05 | 720 | 46 | 9 | int:LYN | |
| Interaction | CALHM6 interactions | 3.05e-05 | 4 | 46 | 2 | int:CALHM6 | |
| Interaction | GJA1 interactions | 4.62e-05 | 583 | 46 | 8 | int:GJA1 | |
| Interaction | DFFB interactions | 4.78e-05 | 31 | 46 | 3 | int:DFFB | |
| Interaction | CNOT6L interactions | 5.98e-05 | 93 | 46 | 4 | int:CNOT6L | |
| Interaction | RAC3 interactions | 7.05e-05 | 619 | 46 | 8 | int:RAC3 | |
| Interaction | C11orf52 interactions | 7.17e-05 | 311 | 46 | 6 | int:C11orf52 | |
| Interaction | RHOJ interactions | 8.24e-05 | 633 | 46 | 8 | int:RHOJ | |
| Interaction | MCAM interactions | 8.51e-05 | 468 | 46 | 7 | int:MCAM | |
| Interaction | FGF14 interactions | 1.20e-04 | 42 | 46 | 3 | int:FGF14 | |
| Interaction | RAC2 interactions | 1.27e-04 | 674 | 46 | 8 | int:RAC2 | |
| Interaction | RHOH interactions | 1.49e-04 | 512 | 46 | 7 | int:RHOH | |
| Interaction | RHOD interactions | 2.93e-04 | 572 | 46 | 7 | int:RHOD | |
| Interaction | RAB35 interactions | 2.96e-04 | 573 | 46 | 7 | int:RAB35 | |
| Interaction | EPHA5 interactions | 3.23e-04 | 144 | 46 | 4 | int:EPHA5 | |
| Interaction | TNP1 interactions | 3.32e-04 | 12 | 46 | 2 | int:TNP1 | |
| Interaction | SPINK4 interactions | 3.32e-04 | 12 | 46 | 2 | int:SPINK4 | |
| Coexpression | ROSS_AML_OF_FAB_M7_TYPE | 6.40e-06 | 70 | 45 | 4 | M4621 | |
| Coexpression | ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT | 2.34e-05 | 97 | 45 | 4 | M39213 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-06 | 195 | 46 | 5 | 1e794839a251fbc6e6ce419b4c457ead35a04735 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.81e-06 | 197 | 46 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 136 | 46 | 4 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 136 | 46 | 4 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 136 | 46 | 4 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 136 | 46 | 4 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 136 | 46 | 4 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-05 | 146 | 46 | 4 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-05 | 157 | 46 | 4 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | ASK428-Immune-Mast_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.41e-05 | 163 | 46 | 4 | 569ca0e8ce307f258910b0c75c498009a9651e6e | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.52e-05 | 165 | 46 | 4 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-05 | 165 | 46 | 4 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-05 | 165 | 46 | 4 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-05 | 165 | 46 | 4 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.58e-05 | 166 | 46 | 4 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-05 | 167 | 46 | 4 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-05 | 167 | 46 | 4 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.71e-05 | 168 | 46 | 4 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.77e-05 | 169 | 46 | 4 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 2.84e-05 | 170 | 46 | 4 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.84e-05 | 170 | 46 | 4 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.90e-05 | 171 | 46 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Eosinophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 171 | 46 | 4 | fa6e856e62b82ec4972e0098e73f237cc611891f | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Eosinophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.04e-05 | 173 | 46 | 4 | a85cead231e03945fabbc7762540ad21fe4299df | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.25e-05 | 176 | 46 | 4 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-05 | 180 | 46 | 4 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-05 | 180 | 46 | 4 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-05 | 180 | 46 | 4 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 3.70e-05 | 182 | 46 | 4 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.95e-05 | 185 | 46 | 4 | 2c07991e0907ded67e21ab2e66be21695842ed01 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-05 | 187 | 46 | 4 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-05 | 187 | 46 | 4 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-05 | 187 | 46 | 4 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-05 | 187 | 46 | 4 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 189 | 46 | 4 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 189 | 46 | 4 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|World / Lineage and Cell class | 4.47e-05 | 191 | 46 | 4 | 91327184ca40bfb8c9e904991b1be503aaccd7bc | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.47e-05 | 191 | 46 | 4 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 192 | 46 | 4 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 192 | 46 | 4 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 192 | 46 | 4 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 192 | 46 | 4 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 4.94e-05 | 196 | 46 | 4 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-05 | 196 | 46 | 4 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-05 | 196 | 46 | 4 | 05b437af66cb43ba098ea93a02dc2f7430bf8c1b | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|hematopoetic_progenitors / Lineage and Cell class | 5.04e-05 | 197 | 46 | 4 | 6172a1b98ff840d9174b1ab20ba0c202a7ef87af | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-05 | 197 | 46 | 4 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-05 | 197 | 46 | 4 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.14e-05 | 198 | 46 | 4 | fcf53d6ac2e442400fa0c07c6de72e00a9143ba2 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.24e-05 | 199 | 46 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Dendritic_Cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.32e-05 | 85 | 46 | 3 | d2776a2c8d1721dbbd7d5dc868a3810e30dd9064 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.59e-04 | 146 | 46 | 3 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.87e-04 | 149 | 46 | 3 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 4.96e-04 | 150 | 46 | 3 | 0a65f5e2f4e0b0e822b029e0222b28ba2db89e6d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 151 | 46 | 3 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.06e-04 | 151 | 46 | 3 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.46e-04 | 155 | 46 | 3 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 156 | 46 | 3 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 156 | 46 | 3 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.56e-04 | 156 | 46 | 3 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-5|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.67e-04 | 157 | 46 | 3 | 59450e9f580555091b159fbbe0a0756e51bcd9ad | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.88e-04 | 159 | 46 | 3 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.99e-04 | 160 | 46 | 3 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-04 | 162 | 46 | 3 | 16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47 | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.21e-04 | 162 | 46 | 3 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 6.32e-04 | 163 | 46 | 3 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.43e-04 | 164 | 46 | 3 | 8f3255d7f67890389a768453492243ea982eb38a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-04 | 164 | 46 | 3 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | VE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 6.78e-04 | 167 | 46 | 3 | 1036ac1ef9440612500137af9d1929672b077e4d | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.90e-04 | 168 | 46 | 3 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-04 | 168 | 46 | 3 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.90e-04 | 168 | 46 | 3 | 1dfe87129fdf4cef71dbc17cf39692f0b8dc3345 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 169 | 46 | 3 | 3ad534303b4b60a77d171e605a1ba2ef20b5e2a3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 169 | 46 | 3 | 29dca061864c86218ab73a86cf6e3c522472da47 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 7.02e-04 | 169 | 46 | 3 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.02e-04 | 169 | 46 | 3 | 150c08c7b1dc0f46173a7b8f6a3fc70d82906c0d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.14e-04 | 170 | 46 | 3 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-04 | 171 | 46 | 3 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.26e-04 | 171 | 46 | 3 | 10492832db8ebc3cf85503c441f33bd94df9458e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.26e-04 | 171 | 46 | 3 | 7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-04 | 171 | 46 | 3 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-04 | 171 | 46 | 3 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-04 | 171 | 46 | 3 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-04 | 171 | 46 | 3 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 7.39e-04 | 172 | 46 | 3 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.39e-04 | 172 | 46 | 3 | 7fb43b3938b9a3b6935ec22d9d853e7d47b82b3c | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.39e-04 | 172 | 46 | 3 | 3a76cfb2832790144a6da6406469ead0767916b5 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.51e-04 | 173 | 46 | 3 | 1e4afa020fae682521335b440ccd33c16f37156f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-04 | 173 | 46 | 3 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.51e-04 | 173 | 46 | 3 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.51e-04 | 173 | 46 | 3 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.64e-04 | 174 | 46 | 3 | 33386750842c47ad7e7286d0f26a556da1a2de02 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.64e-04 | 174 | 46 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 7.64e-04 | 174 | 46 | 3 | 96f1d025af3a5bf616926a558885d196c3cd2709 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.64e-04 | 174 | 46 | 3 | 9344d4e76d7d9429aea87d3c0b98246200d16014 | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | 2.73e-06 | 197 | 46 | 6 | 5097_DN | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 2.38e-06 | 2 | 46 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 2.38e-06 | 2 | 46 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 7.13e-06 | 3 | 46 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 7.13e-06 | 3 | 46 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 6.62e-05 | 8 | 46 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Congenital neutropenia | 1.55e-04 | 12 | 46 | 2 | C0340970 | |
| Disease | response to clozapine | 3.58e-04 | 18 | 46 | 2 | GO_0097338 | |
| Disease | colon cancer (is_implicated_in) | 1.45e-03 | 36 | 46 | 2 | DOID:219 (is_implicated_in) | |
| Disease | respiratory system disease | 1.51e-03 | 145 | 46 | 3 | EFO_0000684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFPYNHRMKKYLSKT | 296 | Q99798 | |
| NHDYLSYDKMKRQKR | 1256 | Q9NR48 | |
| LKYVQNKDVFMRYHK | 441 | Q93034 | |
| HKMYSNKGTLRVHYK | 1041 | Q6ZN30 | |
| KNIMSKVHGKRYAYR | 111 | Q99581 | |
| SRQSIQKYIKSHYKV | 46 | P07305 | |
| SFMKKNGQQLYRHIY | 521 | Q14156 | |
| VMYLYKHPKESRSNK | 661 | Q96ST2 | |
| NMLKKYSHHRNIATY | 71 | O95819 | |
| NYDYQILHKKSMDKS | 1211 | Q16787 | |
| HYQMSVTLKYEIKKL | 26 | Q8N5M9 | |
| RRVMKANQKHIYYIT | 166 | Q58FG0 | |
| LRKYADKIYNISMKH | 296 | Q9HBA9 | |
| MSKKTNRGSQLHKYY | 1471 | P42356 | |
| KNLLKHDSNYAKMYC | 476 | Q8NG31 | |
| QKKYVKVLMHDVAYR | 156 | P16871 | |
| GHKKVLQAMLHYQKY | 236 | Q9Y4D1 | |
| YYKLHNVNRPLTMKK | 376 | P23769 | |
| QKIKYYMGHSHVKLQ | 601 | Q8IUR7 | |
| VKHKATEQYYAMKIL | 61 | P22694 | |
| DHLRKMNKYLQTKYA | 586 | Q8NCX0 | |
| MKYIQHTYRKGVKID | 126 | P52565 | |
| QYYSMLHKYVNRKEK | 271 | Q5R3K3 | |
| VQIHKSMKDLNRKYF | 2206 | Q0VDD8 | |
| SKLNMSNKEYKFYLH | 131 | Q504Y0 | |
| YHHSLKKYMQKTSSI | 661 | Q6UXK5 | |
| HLTNEMKNYMKKSSY | 1191 | Q12923 | |
| NMLKKYSHHRNIATY | 71 | Q8N4C8 | |
| HYYKMSSQEKLNKFL | 1671 | Q5TCS8 | |
| KKRDYQARKMHYLLS | 156 | Q96L03 | |
| HIYNAYLKNFNMTKK | 181 | Q03181 | |
| NLKRLYDKAAKMYHQ | 251 | Q9UPR3 | |
| AYRYLQKAASMNHTK | 206 | Q9UBV2 | |
| HMYSKNKKVSYLSKQ | 256 | Q6UWF7 | |
| KLKMTNNHIYSNKGY | 576 | Q9BZQ2 | |
| SKIHQYKVRAYIQMK | 216 | Q9H9A5 | |
| ITKMALYKNASYKHP | 1931 | O75443 | |
| KYSNSNRYKIRHTKK | 156 | A8MXY4 | |
| NMLKKYSHHRNIATY | 71 | Q9UKE5 | |
| RHYSKQAIKQMYVLI | 2846 | Q96RL7 | |
| TAYNYKKQMHRKFRS | 391 | Q9UNW1 | |
| KRYHTYTQTMRKKDK | 151 | Q9P2N2 | |
| HRQLLKSYKIAYKNK | 401 | Q709C8 | |
| NKYHKLKALMTQRTY | 746 | Q9Y2C9 | |
| YSRVIQVKKMKAIYH | 296 | Q9Y487 | |
| RLYRSVYEKNKMKIH | 4776 | P20929 | |
| DIKYKAHMLKTRNDY | 4876 | P20929 |